Limits amount paid by covered persons for purchase of insulin drugs and epinephrine; requires Division of Consumer Affairs to investigate insulin prices.

This bill caps out-of-pocket costs for insulin and epinephrine under New Jersey health insurance plans at $100 per 30-day supply of insulin or per package of two epinephrine auto-injectors. It requires the Division of Consumer Affairs to investigate insulin pricing practices, gather data from manufacturers and sellers, and assess whether additional consumer protections are needed. Within six months of enactment, the Division must publish a public report detailing findings and recommendations for controlling prices and preventing deceptive sales practices. The bill directly affects insured residents needing these medications, insurance carriers, and manufacturers selling insulin in New Jersey.